Data, AI, and the Future of Field Training with Annel Duckels from BMS
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
In this episode, Jonathan sits down with Annel Duckels, who leads worldwide commercialization learning at Bristol Myers Squibb, to talk about modernizing pharma training through data and AI.
- Annel's unconventional path into pharma L&D after a career in mining and heavy engineering — and what that industry taught her about listening to frontline workers
- Why pharma lagged decades behind other industries in training technology, and what that reveals about corporate priorities
- Moving past "check-the-box" training: building programs from the bottom up instead of top down
- Designing individualized learning experiences instead of one-size-fits-all content
- How AI creates a "safe space" for reps to practice and get anonymous, judgment-free feedback
- Why clean CRM and call-note data is the invisible foundation of every AI training strategy
- How AI is changing HCP engagement as physicians increasingly self-serve medical literature
- Using AI to scale and personalize learning content development
- Giving reps granular, per-conversation performance feedback — beyond what any manager could deliver manually
- A look ahead: what pharma L&D and field enablement could look like a year from now
Pharma Sessions is hosted by Jonathan Kaskey
Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/
Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません